| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.35 | 9e-08 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.31 | 5e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |